Chemical inhibitors of CNOX offer a variety of mechanisms by which they impede the protein's function. Ebselen operates by simulating the activity of glutathione peroxidase, an enzyme critical for mitigating oxidative stress within cells. By mimicking this enzyme's function, Ebselen effectively reduces the oxidative reactions that CNOX typically catalyzes. Similarly, Diphenyleneiodonium chloride takes a direct approach by thwarting the electron transport in flavoproteins, a necessary component of CNOX's enzymatic activities, thereby hindering its function. Apocynin's mode of action is slightly different; it disrupts CNOX activity by preventing the formation of NADPH oxidase complexes, which play a role in the production of reactive oxygen species-a substrate on which CNOX acts. Allopurinol specifically targets xanthine oxidase, leading to a decrease in superoxide production, which CNOX might otherwise use in its catalytic cycle.
Continuing with the array of inhibitory mechanisms, NDGA and Auranofin both modulate aspects of the cellular redox environment, which is crucial to CNOX function. NDGA acts by inhibiting lipoxygenase, altering the synthesis of leukotrienes and thus impacting the redox balance. On the other hand, Auranofin targets thioredoxin reductase, an enzyme integral to maintaining redox homeostasis, and its inhibition can affect CNOX activity. Capsazepine and Sulfasalazine alter signaling pathways within the cell. Capsazepine does this through its antagonistic effect on vanilloid receptors, which are involved in redox-sensitive cellular processes, whereas Sulfasalazine modifies NF-kB signaling, which is connected to the body's oxidative stress response. DPI (Diphenyleneiodonium) takes a more direct approach, similar to its chloride counterpart, by impairing flavoenzymes that are essential for electron transport, a critical step in CNOX's action. Finally, Imidazole, Miconazole, and Ketoconazole disrupt various aspects of metalloenzyme activity and cytochrome P450 enzymes, which are key components in the electron transfer processes and redox cycles that CNOX relies upon for its enzymatic activity. Each of these chemicals, by affecting different pathways and processes, ensures the inhibition of CNOX function through distinct molecular interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $33.00 $136.00 $458.00 | 5 | |
Ebselen inhibits CNOX by mimicking glutathione peroxidase activity, reducing oxidative stress and consequently decreasing the redox reactions essential for CNOX's function. | ||||||
Diphenyleneiodonium chloride | 4673-26-1 | sc-202584E sc-202584 sc-202584D sc-202584A sc-202584B sc-202584C | 10 mg 25 mg 50 mg 100 mg 250 mg 500 mg | $151.00 $136.00 $317.00 $405.00 $944.00 $1837.00 | 24 | |
This compound inhibits CNOX by blocking electron transport in flavoproteins, directly impeding the electron transport chain activities of CNOX. | ||||||
Apocynin | 498-02-2 | sc-203321 sc-203321A sc-203321B sc-203321C | 1 g 10 g 100 g 500 g | $27.00 $68.00 $116.00 $360.00 | 74 | |
Apocynin inhibits CNOX by preventing the assembly of NADPH oxidase complexes, thus reducing reactive oxygen species production and diminishing the redox function of CNOX. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol inhibits CNOX by targeting xanthine oxidase, leading to reduced superoxide production, a reactive oxygen species that CNOX may utilize in its activity. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
NDGA inhibits CNOX by obstructing lipoxygenase, thereby altering leukotriene synthesis and affecting the redox balance that CNOX relies on for its activity. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin inhibits CNOX by inactivating thioredoxin reductase, altering the redox homeostasis which is crucial for the functional activity of CNOX. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Capsazepine inhibits CNOX by antagonizing vanilloid receptors, which may influence redox-sensitive cellular signaling pathways and thus inhibit CNOX activity. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Sulfasalazine inhibits CNOX by modulating NF-kB signaling, potentially decreasing the oxidative stress response which could otherwise enhance CNOX's activity. | ||||||
Imidazole | 288-32-4 | sc-204776 sc-204776A sc-204776B sc-204776C | 25 g 100 g 1 kg 5 kg | $27.00 $56.00 $84.00 $343.00 | 2 | |
Imidazole inhibits CNOX by interfering with metalloenzyme activity, potentially affecting metal cofactor interactions that are vital for the enzymatic function of CNOX. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Miconazole inhibits CNOX by targeting cytochrome P450 enzymes, which may disrupt the redox cycle and electron transfer processes that CNOX depends on. | ||||||